Sébastien Froelich

No ORCID on file · 2 papers in corpus

guideline 2025

Recommendations on the management of meningioma and sex hormone therapy: The results of a collaborative effort between neurosurgical, endocrine and gynecological societies

Brain & spine ·doi:10.1016/j.bas.2024.104154

INTRODUCTION: Exogenous and endogenous sex hormones, especially Progesterone agonists, may be causally linked to meningioma progression. Cessation of treatment leads to stabilization or regression of Progestin-induced meningioma. In many ca…

observational 2024

Prolonged use of nomegestrol acetate and risk of intracranial meningioma: a population-based cohort study

The Lancet regional health. Europe ·doi:10.1016/j.lanepe.2024.100928

BACKGROUND: Nomegestrol acetate (NOMAC) is a synthetic potent progestogen. This study aimed to assess the risk of intracranial meningioma associated with the prolonged use of NOMAC. METHODS: Observational cohort study using SNDS data (Fran…